Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
   Psychedelics In Minnesota: Gov Walz Authorizes Task Force & Safe Consumption Sites Via Omnibus Health Bill
   
  
  May 25, 2023
  From Benzinga
 
   Psychedelics In Colorado: Gov Ratifies Bill, Report Shows No Increase In Public Health Harms
   
  
  May 25, 2023
  From Benzinga
 
   Novel DMT Compound For Anxiety Shows Clinical Progress: Robust Effects Within 2 Minutes
   
  May 24, 2023
  Tickers 
   CYBN
  
  
  From Benzinga
 
   Microdosing LSD For Major Depression Treatment Seeks Further Clinical Validation Via New Study
   
  
  May 24, 2023
  From Benzinga
 From Benzinga
 
   Psychedelics Reform Update: MI's Task Force, NC's $5M Fund, CA's Fed Follow-Up, ME Tables Proposal
   
  
  May 23, 2023
  From Benzinga
 From Benzinga
 
   Canadians Share Insights On Psychedelics: Survey Reveals Real-World Use And Access Trends
   
  
  May 21, 2023
  From Benzinga
 
   This Biotech Company Discovers What May Be The First New Compounds Of Psilocybin In History
   
  
  May 19, 2023
  From Benzinga
 
   MindMed's LSD Study For Anxiety Treatment Enrolls And Doses 100 Participants, More Expected
   
  May 19, 2023
  Tickers 
   MNMD
  
  
  From Benzinga
 
   PharmAla Biotech Nabs First-Ever Canadian Approval To Provide MDMA Treatment Outside Clinical Setting
   
  
  May 18, 2023
  From Benzinga
 
   The Psychedelic Mushrooms Market; Between Legitimate Harvesting And Illegal Retail Sales
   
  May 17, 2023
  Tickers 
   OPTHF
  
  
  From Benzinga
 
   African Iboga Root Heads To Canadian Company Developing Natural Drugs To Help Treat Addictions
   
  May 17, 2023
  Tickers 
   FLHLF
  
  
  From Benzinga
 
   Seelos Therapeutics Positive Q1 Financials Make For 'The Most Important Year' In Company's History
   
  May 16, 2023
  Tickers 
   SEEL
  
  
  From Benzinga
 
   Psychedelic Therapies Soon Available In Australia Via Incannex Healthcare And Subsidiary
   
  May 16, 2023
  Tickers 
   IXHL
  
  
  From Benzinga
 
   Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More
   
  
  
  May 15, 2023
  From Benzinga
 From Benzinga
 From Benzinga
 
   Psychedelics Reform Update: AZ Budget Includes Psilocybin Research, ME's Psilocybin Act & More
   
  May 14, 2023
  Tickers 
   DEA
  
  
  From Benzinga
 
   EXCLUSIVE: Lessons From Psychedelics Markets Through Business, Legal And Reciprocity Lenses
   
  May 12, 2023
  Tickers 
   BWVI
  
  
  From Benzinga
 
   Terran Biosciences' Four Patent Applications Cover Improved Versions Of Classic Empathogens
   
  
  May 12, 2023
  From Benzinga
 
   EXCLUSIVE: Clearmind Medicine Secures Approval To Launch Clinical Trial For Alcohol Addiction Treatment
   
  May 12, 2023
  Tickers 
   CMND
  
  
  From Benzinga
 
   GH Research: Q1 2023 Financials And Businesses For European 5-MeO-DMT Depression Treatment Developer
   
  May 11, 2023
  Tickers 
   GHRS
  
  
  From Benzinga
 
   COMPASS Pathways Reports Q1 2023: Financials, Commercial Groundwork And Ongoing Phase 3 Trials
   
  May 11, 2023
  Tickers 
   CMPS
  
  
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.